Research Topics
Genomes and GenesSpecies | D S CooperSummaryAffiliation: Sinai Hospital of Baltimore Country: USA Publications
| Collaborators
|
Detail Information
Publications
The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trialMilena Braga
Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
Thyroid 12:135-9. 2002..Similar cure rates and time required to achieve hypothyroidism after radioiodine were observed when patients were pretreated with methimazole compared to nonpretreated patients...
Subclinical thyroid disease: consensus or conundrum?David S Cooper
Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
Clin Endocrinol (Oxf) 60:410-2. 2004
Antithyroid drugsDavid S Cooper
Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
N Engl J Med 352:905-17. 2005
Approach to the patient with subclinical hyperthyroidismDavid S Cooper
Division of Endocrinology, Sinai Hospital of Baltimore, 2435 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215, USA
J Clin Endocrinol Metab 92:3-9. 2007..Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range...
Thoughts on prevention of thyroid disease in the United StatesDavid S Cooper
Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Thyroid 12:925-9. 2002..Together, these data suggest that the notion of preventive medicine in the United States should be expanded to include thyroid disease as a target for secondary and tertiary intervention...
HyperthyroidismDavid S Cooper
Division of Endocrinology, Sinai Hospital of Baltimore, Johns Hopkins University School of Medicine, MD 21215 5271, USA
Lancet 362:459-68. 2003..The more unusual causes of hyperthyroidism, including struma ovarii, thyrotropin-secreting tumours, choriocarcinoma, and amiodarone-induced thyrotoxicosis are, more often than not, a challenge to diagnose and treat...
Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversiesDavid S Cooper
Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215, USA
J Clin Endocrinol Metab 88:3474-81. 2003
Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administrationM Braga
Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Baltimore, Maryland 21215, USA
J Clin Endocrinol Metab 86:5148-51. 2001..Based on these cases, and other reports of rapid tumor expansion after rhTSH injection, we recommend glucocorticoid coverage before rhTSH administration for patients with known or suspected neoplasia located in a limited space...
Graves' disease and recurrent ectopic thyroid tissueS Basaria
Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Thyroid 9:1261-4. 1999..It recurred 9 years later when the patient developed Graves' disease. We propose that the recurrence of the ectopic thyroid tissue was due to the influence of thyroid stimulating immunoglobulins (TSI)...
Clinical review 129: Oral cholecystographic agents and the thyroidM Braga
Division of Endocrinology and Metabolism, Sinai Hospital, Baltimore, Maryland 21215, USA
J Clin Endocrinol Metab 86:1853-60. 2001..The lack of significant side effects makes these drugs an excellent short-term option in situations where a rapid clinical improvement is critical...
Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literatureR J Behrens
National Cancer Institute, Bethesda, Maryland, USA
Thyroid 11:697-705. 2001..The first patient also received radiotherapy to his thyroid bed and scalp. We summarize the prior reported cases of LCH involving the thyroid and review the current treatment modalities used for LCH...
Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008Ana B Emiliano
Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, Maryland 21287, USA
J Clin Endocrinol Metab 95:2227-33. 2010..However, little is known about the rate of use of these drugs and the prescribing practices of physicians treating hyperthyroidism...
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinomaE L Mazzaferri
Division of Endocrinology, Shands Hospital, Gainesville, Florida 32610, USA
J Clin Endocrinol Metab 88:1433-41. 2003....
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawalPamela R Schroeder
Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
J Clin Endocrinol Metab 91:878-84. 2006..CONCLUSIONS: Short-term hypothyroidism after L-T4 withdrawal is associated with a significant decline in quality of life that is abrogated by rhTSH use...
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancerDavid S Cooper
The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
Thyroid 19:1167-214. 2009..Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in 2006, a large amount of new information has become available, prompting a revision of the guidelines...
The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancerMilena Basaria
Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
Am J Med 112:721-5. 2002..The use of recombinant thyrotropin has fewer adverse effects than does the alternative, which is withdrawal of thyroid hormone replacement, although nausea and headache have been reported. However, recombinant thyrotropin is expensive...
Amiodarone and the thyroidShehzad Basaria
Department of Medicine, Division of Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, Maryland, USA
Am J Med 118:706-14. 2005....
Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancerShuiying Hu
Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
J Clin Endocrinol Metab 91:98-104. 2006..CONCLUSIONS: We have demonstrated the potential usefulness of serum DNA methylation markers as a novel tool for differential diagnosis of solid thyroid nodules and thyroid cancer recurrence monitoring...
TSH suppressive therapy: an overview of long-term clinical consequencesDavid S Cooper
Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
Hormones (Athens) 9:57-9. 2010..g., osteoporosis, cardiovascular disease, diabetes), is uncertain and requires a high degree of clinical experience and judgment...
Amyloidosis: role of fine-needle aspirationShehzad Basaria
Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
Thyroid 13:313-4. 2003
Dirty nailsHans K Ghayee
Sinai Hospital, Department of Medicine, 2401 West Belvedere Avenue, Baltimore, Maryland 21215, USA
J Clin Endocrinol Metab 90:2428. 2005
Can amiodarone be restarted after amiodarone-induced thyrotoxicosis?Laura E Ryan
Department of Internal Medicine, Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University, Columbus, OH, 43210, USA
Thyroid 14:149-53. 2004..One such case is outlined here and discussed by a panel of experts...
Outcomes of patients with differentiated thyroid carcinoma following initial therapyJacqueline Jonklaas
Georgetown University Medical Center, Washington, DC 20007, USA
Thyroid 16:1229-42. 2006..We were unable to show any impact, positive or negative, of specific therapies in stage I patients...
Combined T4 and T3 therapy--back to the drawing boardDavid S Cooper
JAMA 290:3002-4. 2003
Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trialsMartin A Walter
Institute of Nuclear Medicine, University Hospital Basel, Switzerland
BMJ 334:514. 2007..To determine the effect of adjunctive antithyroid drugs on the risk of treatment failure, hypothyroidism, and adverse events after radioiodine treatment...
The clinical significance of subclinical thyroid dysfunctionBernadette Biondi
Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S Pansini 5, 80131 Naples, Italy
Endocr Rev 29:76-131. 2008..Lastly, we address the issue of the need to treat slight thyroid hormone deficiency or excess in relation to the patient's age...
Expanding indications for recombinant human TSH in thyroid cancerBryan R Haugen
Thyroid 18:687-94. 2008
Review on the occasion of a decade of recombinant human TSH: prospects and novel usesLeonidas H Duntas
Endocrine Unit, Evgenidion Hospital, University of Athens, Medical School, 20 Papadiamantopoulou Street, Athens, Greece
Thyroid 18:509-16. 2008..Finally, rhTSH may prove to be useful in studying the functional reserve of thyroid in the aging process, as well as the putative role of the TSH receptor in extrathyroidal tissue, such as lymphocytes, osteocytes, and adipocytes...
Thyroxine monotherapy after thyroidectomy: coming full circleDavid S Cooper
JAMA 299:817-9. 2008
Thyroid disease in the oldest old: the exception to the ruleDavid S Cooper
JAMA 292:2651-4. 2004
Management guidelines for patients with thyroid nodules and differentiated thyroid cancerDavid S Cooper
Sinai Hospital of Baltimore and Johns Hopkins University School of Medicine, MD, USA
Thyroid 16:109-42. 2006
